Tonsil and Adenoid Removal Products Market Size (2024 - 2029)

The tonsil and adenoid removal products market is projected to experience growth over the forecast period, driven by the resumption of non-urgent and elective procedures following the COVID-19 pandemic. The initial impact of the pandemic led to a significant decrease in procedures due to lockdowns and the prioritization of critical surgeries, but the market is expected to regain its pre-COVID momentum. The increasing prevalence of tonsil and adenoid infections is further contributing to the market's expansion. However, complications associated with these surgeries may pose challenges to market growth.

Market Size of Tonsil and Adenoid Removal Products Industry

Tonsil and Adenoid Removal Products Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 7.30 %
Fastest Growing Market North America
Largest Market Asia Pacific

Major Players

Tonsil and Adenoid Removal Products Market Major Players

*Disclaimer: Major Players sorted in no particular order

Tonsil & Adenoid Removal Products Market Analysis

The tonsil & adenoid removal products market is expected to register a CAGR of 7.3% over the forecast period.

The COVID-19 pandemic has had a substantial impact on the tonsil & adenoid removal products market initially. The imposition of lockdown and delay of non-urgent surgeries and non-COVID disease treatment decreased the number of tonsil and adenoid procedures in 2020. The high risk of COVID-19 led to prioritizing only critical surgeries and procedures, which restricted various otolaryngology services. For instance, in a study published in the Journal of Head and Neck in February 2022, the number of tonsil surgery decreased by up to 82% in Germany due to the pandemic. According to a study published in the Journal Laryngoscope Investigative Otolaryngology in July 2021, along with the delay and cancellation of elective surgeries during a pandemic. The COVID-19 lockdown decreased the incidence rates of tonsil infections, such as in children, which also led to a decrease in the volume of tympanostomies and tonsil surgeries in children. However, even during the pandemic, severe cases of tonsil surgeries were allowed and performed. For instance, in a study published in the European Annals of Otorhinolaryngology, Head and Neck Diseases in May 2020, tonsillectomy and adenoidectomy were performed without any delay in the case of severe obstructive sleep apnea syndrome in adults. Although, with the lifting of the lockdown and the resumption of the non-COVID, non-urgent, and elective procedures, the market is expected to regain its normal pace as it was in pre-COVID. For instance, in February 2022, the New South Wales Government announced the resumption of non-urgent elective surgeries and increased the overnight stay of the patients by 85% of pre-pandemic activity levels in the private hospitals. Further, in May 2022, the New York State Department of Health (DOH) announced the updated guideline for the resumption of nonurgent procedures and non-essential elective surgeries in hospitals, office-based surgery practices, diagnostic and treatment centers, and ambulatory surgery centers.

The market is expected to grow further at a stable pace with the lifting of the lockdown and the resumption of the non-COVID, non-urgent, and elective procedures globally.

Further, the increasing cases of tonsil and adenoid infections are also boosting the market's growth. According to a study published in the Lancet in June 2022, the pooled incidence rate of the group A Streptococcus throat infection calculated for children was 82.2 episodes per 100 child years for sore throat and 22.1 episodes per 100 child years for Strep A sore throat. A study published in Journal Nature in December 2022 has underlined the risk of the surging case of strep A after the death of over 13 children in the United Kingdom in the month of December 2022, which causes deadly scarlet fever. According to the STAT Pearls in 2021, the condition of adenoid hypertrophy has a prevalence rate of 34.5% in children.

Therefore, owing to the increasing prevalence of tonsil and adenoid infections, the studied market is anticipated to witness growth over the analysis period. However, the complication associated with the surgeries is likely to impede the market growth.

Tonsil & Adenoid Removal Products Industry Segmentation

As per the scope of the report, tonsils and adenoid removal products are used in surgeries related to throat infections. The products help in diagnosing disorders such as sleep apnea and other respiratory tract infections. The Tonsil & Adenoid Removal Products Market is segmented by Type (Tonsils Removal Products (Forceps, Wireloop, and Scissors) and Adenoid Removal Products (Microdebrider)), Technology (Electrocautery (ECT), Coblation, Harmonic Scalpel), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type
Tonsils Removal Products
Forceps
Wire loop
Scissors
Adenoid Removal Products
Microdebrider
By Technology
Electrocautery (ECT)
Coblation
Harmonic scalpel
Other Technologies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Tonsil and Adenoid Removal Products Market Size Summary

The tonsil and adenoid removal products market is poised for growth, driven by the resumption of non-COVID, non-urgent, and elective procedures following the disruptions caused by the pandemic. Initially, the market experienced a downturn due to the prioritization of critical surgeries and the postponement of elective procedures, which significantly reduced the number of tonsil and adenoid surgeries. However, as lockdowns were lifted and healthcare systems resumed normal operations, the market began to recover. The increasing prevalence of tonsil and adenoid infections, particularly among children, is further propelling market expansion. The adoption of advanced surgical techniques, such as coblation, which offers benefits like reduced bleeding and pain, is also contributing to the market's growth trajectory.

North America is expected to lead the market, supported by a high incidence of tonsil, adenoid, and respiratory infections, alongside a substantial volume of surgical procedures. The region's healthcare landscape is characterized by a significant number of tonsillectomies and adenoidectomies performed annually, driven by the prevalence of conditions such as chronic obstructive pulmonary disease and influenza-related illnesses. The competitive landscape of the market is moderately fragmented, with several global and regional players like Medtronic, Olympus America, and Smith & Nephew holding notable market shares. These companies are actively innovating and expanding their offerings to capture a larger share of the market, as evidenced by recent product launches and strategic expansions.

Explore More

Tonsil and Adenoid Removal Products Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Infecton in Tonsils and Adenoid

      2. 1.2.2 Increasing number of Respiratory Tract Infection

    3. 1.3 Market Restraints

      1. 1.3.1 Complication Associated with the Surgeries

    4. 1.4 Porter Five Forces

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 Tonsils Removal Products

        1. 2.1.1.1 Forceps

        2. 2.1.1.2 Wire loop

        3. 2.1.1.3 Scissors

      2. 2.1.2 Adenoid Removal Products

        1. 2.1.2.1 Microdebrider

    2. 2.2 By Technology

      1. 2.2.1 Electrocautery (ECT)

      2. 2.2.2 Coblation

      3. 2.2.3 Harmonic scalpel

      4. 2.2.4 Other Technologies

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Tonsil and Adenoid Removal Products Market Size FAQs

The Tonsil and Adenoid Removal Products Market is projected to register a CAGR of 7.30% during the forecast period (2024-2029)

Medtronic, BAUSCH & LOMB INCORPORATED , Olympus America, New Med Instruments and medelecsurgical are the major companies operating in the Tonsil and Adenoid Removal Products Market.

Tonsil and Adenoid Removal Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)